Pivka-Ii
Tsuchiya, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 536-539
1999
ISSN/ISBN: 0047-1852 PMID: 10778184 Document Number: 509338
Document emailed within 1 workday
Related Documents
Mizobuchi, N.; Yamasaki, M.; Nizawa, I.; Iwata, K.; Niiya, K. 1986: PIVKA-Ii in patients with liver diseases Rinsho Byori. Japanese Journal of Clinical Pathology 34(1): 95-99Okuda, H.; Nakanish, T.; Furukawa, M.; Yamagata, H.; Obata, H. 1991: Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 12(2): 59-66
Baek, Y.-H.; Lee, J.-H.; Jang, J.-S.; Lee, S.-W.; Han, J.-Y.; Jeong, J.-S.; Choi, J.-C.; Kim, H.-Y.; Han, S.-Y. 2009: Diagnostic role and correlation with staging systems of PIVKA-Ii compared with AFP Hepato-Gastroenterology 56(91-92): 763-767
Laosombat, V.; Kenpitak, K.; Wongchanchailert, M.; Wiriyasateinkul, A. 1993: Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand Journal of the Medical Association of Thailand 76(5): 278-284
von Kries, R.; Shearer, M.J.; Widdershoven, J.; Motohara, K.; Umbach, G.; Göbel, U. 1992: Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers Thrombosis and Haemostasis 68(4): 383-387
Koh, T.; Taniguchi, H.; Katoh, H.; Kunishima, S.; Yamaguchi, A.; Yamagishi, H. 2002: Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma? Hepato-Gastroenterology 49(48): 1615-1618
Fujiyama, S.; Morishita, T.; Sagara, K.; Sato, T.; Motohara, K.; Matsuda, I. 1986: Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma Hepato-Gastroenterology 33(5): 201-205
Sakizono, K.; Oita, T.; Eto, M.; Bito, S.; Takegawa, H.; Kasakura, S. 2002: Studies on the mechanism of elevation of serum PIVKA-Ii levels in alcoholic liver cirrhosis Rinsho Byori. Japanese Journal of Clinical Pathology 50(3): 289-295
Sakon, M.; Monden, M.; Gotoh, M.; Kobayashi, K.; Kanai, T.; Umeshita, K.; Endoh, W.; Mori, T. 1991: The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma American Journal of Gastroenterology 86(3): 339-345
Bakhshi, S.; Deorari, A.K.; Roy, S.; Paul, V.K.; Singh, M. 1996: Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route Indian Pediatrics 33(12): 1040-1043
Uluşahin, N.; Arsan, S.; Ertogan, F. 1996: Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-Ii assay parameters in breastfed infants in Turkey Turkish Journal of Pediatrics 38(3): 295-300
Hasegawa, Y.; Tomita, K.; Hashimoto, K.; Shigeoka, Y.; Watanabe, M.; Yamasaki, A.; Shimizu, E. 2005: Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation Anticancer Research 25(6c): 4569-4571
Sakurabayashi, I.; Kawai, T.; Omizo, R.; Hattori, N.; Ishii, M. 1988: Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023) Rinsho Byori. Japanese Journal of Clinical Pathology 36(12): 1407-1412
Chimura, T.; Morisaki, N.; Hirayama, T. 1987: Effects of cefotetan on PIVKA-Ii changes in the treatment of infections and prophylaxis of surgical infections in the fields of obstetrics and gynecology Japanese Journal of Antibiotics 40(12): 1964-1968